Vertex Pharmaceuticals Inc. shares surged 1.2% in premarket trade Wednesday after the company announced that Tom Graney would be its new chief financial officer and senior vice president, starting September 13. Graney will report to Ian Smith, Vertex’s chief operating officer and executive vice president, who has been Vertex’s chief financial officer for 16 years. Graney most recently served as CFO and senior vice president of finance and corporate strategy at Ironwood Pharmaceuticals . Graney was in his Ironwood Pharma position for just over three years, according to his LinkedIn profile; he previously worked at Johnson & Johnson and its Ethicon and Janssen business units, among other places. Vertex shares have surged 24.6% to $159.07 over the last three months, compared with a 1.2% rise in the S&P 500 .
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
From:: Stock Market News